Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents

Cancer Chemotherapy and Pharmacology

Volumn 52, Issue 3, 2003, Pages 185-192

  Vernole, Patrizia ^a   Pepponi, Rita ^b   D'Atri, Stefania ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

6 Thioguanine; Chromosomal damage; Cisplatin; Mismatch repair; N (2 Chloroethyl) N cyclohexyl N nitrosourea

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; LOMUSTINE; TEMOZOLOMIDE; TIOGUANINE;

ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DAMAGE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MISMATCH REPAIR; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ANTINEOPLASTIC AGENTS; BASE PAIR MISMATCH; CHROMOSOME ABERRATIONS; HUMANS; SISTER CHROMATID EXCHANGE; TUMOR CELLS, CULTURED;

EID: 0141452189     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0660-6     Document Type: Article

References (40)

1. Aebi S, Fink D, Gordon R, Kim HK, Zheng H, Fink JL, Howell SB (1997) Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res 3:1763
2. Allan MJ, Engelward BP, Dreslin AJ, Wyatt MD, Tomasz M, Samson LD (1998) Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. Cancer Res 58:3965
3. Aquilina G, Ceccotti S, Martinelli S, Hampson R, Bignami M (1998) N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosurea sensitivity in mismatch repair-defective human cells. Cancer Res 58:135
4. Armstrong MJ, Galloway SM (1997) Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents. Mutat Res 373:167
5. Bean CL, Bradt CI, Hill R, Johnson TE, Stallworth MV, Galloway SM (1994) Chromosome abs: persistence of alkylation damage and modulation of O6-alkylguanine-DNA alkyltransferase. Mutat Res 307:67
6. Beranek DT (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 231:11
7. 6-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1,3-bis(2-chloroethyl)-1-nitrosurea. Carcinogenesis 7:879
8. D'Atri S, Tentori L, Lacal PM, Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E, Jiricny J (1998) Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol 54:334
9. 6-alkyltransferase (AT) in cancer chemotherapy. Cancer Treat Rev 15:279
10. Dolan EM, Moshel RC, Pegg AE (1990) Depletion of O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci U S A 87:5368
11. Duckett DR, Drummond JT, Murchie AI, Reardon JT, Sancar A, Lilley DM, Modrich P (1996) Human MutSα recognizes damaged DNA base pairs containing O-6-methylguanine O-4-methylthymine, or the cisplatin-d (GpG) adduct. Proc Natl Acad Sci U S A 93:6443
12. Durant ST, Morris MM, Illand M, McKay HJ, McKormick C, Hirst GL, Borts RH, Brown R (1999) Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes. Curr Biol 9:51
13. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehmè A, Christen RD, Howell SB (1996) The role of DNA mismatch repair in platinum drug resistance. Cancer Res 56:4881
14. Fink D, Aebi S, Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1
15. Fiumicino S, Martinelli S, Colussi C, Aquilina G, Leonetti C, Crescenzi M, Bignami M (2000) Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts. Int J Cancer 85:590
16. Galloway SM, Greenwood SK, Hill R, Bradt CI, Bean CL (1995) A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells. Mutat Res 346:231
17. Goldmacher VS, Cuzick RA, Thilly WG (1986) Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosurea and N-methyl-N′-nitro-N-nitrosoguanidine. J Biol Chem 261:12462
18. Hansen MB, Nielsen SE, Berg K (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203
19. Hawn MT, Umar A, Carethers JM, Marra G, Kunkel TA, Boland CR, Koi M (1995) Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res 55:3721
20. Jiricny J (1998) Eukaryotic mismatch repair: an update. Mutat Res 409:107
21. Jiricny J, Nystrom-Lahti M (2000) Mismatch repair defects in cancer. Curr Opin Genet Dev 10:157
22. Kaina B, Ziouta A, Ochs K, Coquerelle T (1997) Chromosomal instability, reproductive cell death and apoptosis induced by O6-methyl-guanine in Mex-, Mex + and methylation-tolerant mismatch repair compromised cells: facts and models. Mutat Res 381:227
23. Karran P (2001) Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 22:1931
24. Karran P, Bignami M (1992) Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res 20:2933
25. Kat A, Thilly WG, Fang WH, Longley MJ, Li GM, Modrich P (1993) An alkylation-tolerant mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci U S A 90:6424
26. Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, Boland CR (1994) Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 54:4308
27. Liu L, Markowitz S, Gerson SL (1996) Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis (2-chloroethyl)nitrosourea. Cancer Res 56:5375
28. Ludlum DB (1990) DNA alkylation by haloethylnitrosureas: nature of modifications produced and their enzymatic repair or removal. Mutat Res 233:117
29. Mello JA, Acharya S, Fishel R, Essingmann JM (1996) The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol 3:579
30. Modrich P (1997) Strand-specific mismatch repair in mammalian cells. J Biol Chem 272:24727
31. Papadopoulos N, Nicoladesi NC, Wei YF, Ruben SM, Carte KC, Rosen CA, Haseltine WA, Fleishmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin JP, de la Chapelle A, Kinzler KW, Vogelstein B (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625
32. 6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51:167
33. Perry P, Wolff S (1974) New Giemsa method for the differential staining of sister chromatids. Nature 251:156
34. Roberts JJ, Friedlos F (1987) Quantitative estimation of cisplatinum induced DNA interstrand cross-links and their repair in mammalian cells: relationship to toxicity. Pharmacol Ther 34:215
35. 6-methylguanine-DNA methyltransferase. Nucleic Acids Res 22:7743
36. Skopek TR, Liber HL, Penman BW, Thilly WG (1978) Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay. Biochem Biophys Res Commun 84:411
37. Swarm PF, Waters TR, Moulton DC, Xu YZ, Zheng Q, Edwards M, Mace R (1996) Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273:1109
38. Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG (1998) The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res 58:3579
39. Vernole P, Tedeschi B, Caporossi D, Maccarrone M, Melino G, Annicchiarico-Petruzzelli M (1998) Induction of apoptosis by bleomycin in resting and cycling human lymphocytes. Mutagenesis 13:209
40. 6-Alkylguanine-DNA alkyltransferase assays. In: Brown R, Boeger-Brown U (eds) Cytotoxic drug resistance mechanisms. Humana Press, Totowa, p 167